Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
2022 | Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P Global BMI Index | CI |
2022 | Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2020 | 0.98 | Sales 2021 | 1.1 | Capitalization | 102M |
---|---|---|---|---|---|
Net income 2020 | -81M | Net income 2021 | -90M | EV / Sales 2020 | 309,973,492 x |
Net cash position 2020 | 25.21M | Net cash position 2021 | 16.78M | EV / Sales 2021 | 77,011,319 x |
P/E ratio 2020 |
-3.73
x | P/E ratio 2021 |
-1.11
x | Employees | 76 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19-07-10 | |
Jean K. Mixer
BRD | Director/Board Member | 57 | 19-09-29 |
Anthony Quinn
BRD | Director/Board Member | 62 | 16-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.0001 | 0.00% | 494 |
24-04-22 | 0.0001 | 0.00% | 1,250 |
24-04-18 | 0.0001 | 0.00% | 935 |
24-04-17 | 0.0001 | 0.00% | 305 |
Delayed Quote OTC Markets, April 24, 2024 at 02:09 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.26K | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- KLDO Stock